Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pharmacodynamic phase

Drugp act in various ways in the body. Oral drugp go through three phases the pharmaceutic phase, pharmacokinetic phase, and pharmacodynamic phase Liquid and parenteral drug (drug given by injection) go through the later two phases only. [Pg.6]

Among chemical-physics properties, lipophilicity is certainly a key parameter to understand and predict absorption, distribution, metabolism, excretion, and toxicity (ADMET) of NCE furthermore, it contributes to model ligand-target interactions underlying the pharmacodynamic phase [15],... [Pg.52]

Structural Integrity of a Drug Molecule Pharmaceutical, Pharmacokinetic and Pharmacodynamic Phases... [Pg.10]

Optimization of the lead compound for the pharmacodynamic phase (section 3.4)... [Pg.108]

When using QSAR calculations to optimize a drug for the pharmacodynamic phase, it is important to use relevant biological activities. If in vivo activities are used, the bioactivities will be influenced by pharmacokinetic and pharmaceutical factors. In order for QSAR calculations to reflect the pharmacodynamic phase, the bioactivities should be based on in vitro data — optimally, receptor binding studies. [Pg.145]

QSAR studies are not restricted to the optimization of biological activity at the pharmacodynamic phase. Since toxicity also arises from drug-receptor interactions, the QSAR... [Pg.145]

Once the lead dmg molecule has been optimized for the pharmacodynamic phase, it must next be optimized for the pharmacokinetic and pharmaceutical phases. If a dmg molecule cannot withstand the trip from the gut to the receptor microenvironment, it makes no difference whether the drug actually binds to the receptor. [Pg.146]

Figure 3.11 Failure of drug molecules. Many drugs that are successful in the pharmacodynamic phase ultimately fail to become useful drugs. This pie-chart presents the reasons for failure at this stage of the development process. Toxicity is an important cause of failure. Figure 3.11 Failure of drug molecules. Many drugs that are successful in the pharmacodynamic phase ultimately fail to become useful drugs. This pie-chart presents the reasons for failure at this stage of the development process. Toxicity is an important cause of failure.
Define the terms pharmacokinetic phase and pharmacodynamic phase in the context of drug action. List the main general factors that affect these phases. [Pg.55]

For definitions see Section 2.7. The factors affecting the pharmacokinetic phase are ADME. The factor affecting the pharmacodynamic phase is the stereoelectronic structure of the drug molecule. [Pg.262]

Shape and stereochemical. These properties affect the pharmacodynamic phase of drug action and influence the drug s interaction with its target receptor. Shape and stereochemical properties describe the structural arrangement of the drug molecule s constituent atoms and influence the molecule s final approach toward the target receptor. [Pg.37]

Electronic. Electronic properties also affect the pharmacodynamic phase of drug action. The electronic properties of a molecule are governed by the... [Pg.37]

In both pharmacokinetic and pharmacodynamic considerations, an important emphasis concerns the rate at which events occur and the rate at which circumstances change. The pharmacokinetic phase covers the relationship between drug input and the concentration achieved over time. The pharmacodynamic phase covers the relationship between concentration and the therapeutic effect over time (toxicodynamics is concerned with the relationship between concentration and adverse effects over time). [Pg.146]

This pharmacokinetic phase/pharmacodynamic phase model of dose-response can be described physiologically by considering each component of the phase as being separated by lipid membrane barriers that divide essentially aqueous environments. [Pg.141]

In the foregoing sections, pharmacon metabolism has been considered in relation to the pharmacodynamic, especially toxic aspects of action. Drug distribution also plays a role in the pharmacodynamic phase of drug action. Modulation of drug distribution, for instance, exclusion of penetration of particular barriers in the organism (e.g. the blood-brain barrier), or preferential bioactivation or bioinactivation in particular tissues, can modulate the spectrum of action of compounds and possibly exclude particular undesired effects. [Pg.25]

Pharmacodynamic Phase This is the effect the drug has on the body. [Pg.23]


See other pages where Pharmacodynamic phase is mentioned: [Pg.7]    [Pg.726]    [Pg.17]    [Pg.17]    [Pg.19]    [Pg.21]    [Pg.32]    [Pg.67]    [Pg.101]    [Pg.134]    [Pg.32]    [Pg.6]    [Pg.49]    [Pg.53]    [Pg.32]    [Pg.33]    [Pg.33]    [Pg.1]    [Pg.258]    [Pg.4]    [Pg.5]    [Pg.63]    [Pg.67]    [Pg.14]   
See also in sourсe #XX -- [ Pg.10 , Pg.17 , Pg.18 , Pg.134 , Pg.135 , Pg.136 , Pg.137 , Pg.138 ]

See also in sourсe #XX -- [ Pg.10 ]




SEARCH



Drug action pharmacodynamic phase

Drug activity phases pharmacodynamic phase

Drugs pharmacodynamic phase

Pharmacodynamic

Pharmacodynamic phase model

Pharmacodynamic phase, defined

The pharmacodynamic phase

© 2024 chempedia.info